Evogene
Biotechnology
Healthcare
EVGN
6.80 M shares
NASDAQ US
traded
18 Aug 2025
listed
no
open
1.37
52 week high
8.20
high
1.41
52 week low
0.00
previous Close
1.35
P/E ratio
market cap
11.71 M
div yield
0
net profit margin
0.00 %
105.00 %
operating incoming
0.00 %
net change in cash
0.00 %
top